SUEZ the first and only company accredited for detection and quantification of SARS-CoV-2 virus through rapid PCR wastewater monitoring techniques

LABAQUA, which belongs to SUEZ España and is a leading laboratory in the provision of environmental analysis and solutions, has received accreditation from ENAC, the Spanish National Accreditation Body, for the detection and quantification of the SARS-CoV-2 virus, in accordance with the ISO 17025:2017 Standard. The company will apply different qPCR analytical methods for the rapid detection and quantification of genomic units. LABAQUA thus becomes the first and, to date, the only laboratory in Spain to receive this accreditation from the ENAC, the agency appointed by the Government to operate as Spain’s sole National Accreditation Body.

Rapid qPCR analysis in the laboratory is a fundamentally important pillar of robust, reliable methods that provide a guarantee in terms of the quality of results.  LABAQUA has obtained accreditation for two methods. The first method is based on a protocol proposed by the Ministry of Ecological Transition and Demographic Challenge. SUEZ has played a leading role in the second method, which is based on international benchmarks developed within the framework of the international REVEAL project, led by SUEZ’s CETAQUA technology centre and the Department of Aquatic Virology at the University of Barcelona, headed by Albert Bosch. This method achieves enhanced detection limits, thus facilitating better monitoring of the evolution of the virus.

SUEZ’s analytical methodology is a central pillar of the COVID-19 CITY SENTINEL epidemiological control network, a solution which combines an adaptive sampling plan, rapid RT-qPCR analysis, data filtration and analysis using algorithms based on Artificial intelligence, and access to a comprehensive digital pandemic monitoring observatory. This solution is currently being implemented in several parts of Spain for the purpose of monitoring the evolution of the virus in wastewater, thus enabling the anticipation of potential new outbreaks.